HIV-1 DNA vaccines and chemokines

Vaccine

Volumn 17, Issue SUPPL. 2, 1999, Pages

  Boyer, Jean D ^a   Kim, Jong ^a   Ugen, Ken ^b   Cohen, Adam D ^a   Ahn, Lois ^a   Schumann, Kristen ^a   Lacy, Kim ^c   Bagarazzi, Mark L ^d   Javadian, Ali ^e   Ciccarelli, Richard B ^f   Ginsberg, Richard S ^f   MacGregor, Rob Roy ^c   Weiner, David B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e White Sands Research Center   (United States)

^f WLVP Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLASMID VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELLULAR IMMUNITY; CHIMPANZEE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE TARGETING; GENE TECHNOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033215528     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00235-2     Document Type: Conference Paper

References (34)

1. Report on the global HIV/AIDS epidemic. UNAIDS/WHO, 1998.
2. Walker B.D. The rationale for immunotherapy in HIV-1 infection. JAIDS. 7:1994;s6-13.
3. Haynes B.F., Pantaleo G., Fauci A.S. Toward an understanding of the correlates of protective immunity to HIV infection. Science. 271:1996;324-328.
4. Ugen K.E., Srikantan V., Goedert J.J., Nelson R.P., Williams W.V., Weiner D.B. Vertical transmission of immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope. J. Inf. Dis. 175:1997;63-69.
5. Ugen K.E., Goedert J.J., Boyer J., Refaeli Y., Frank I., Williams W.V., Willoughby A., Landesman S., Rubinstein A., Kieber-Emmons T., Weiner D.B. Vertical transmission of HIV infection: reactivity of maternal sera with glycoprotein120 and 41 peptides from HIV type 1. J. Clin. Invest. 89:1992;1923-1930.
6. Rossi P., Moschese V., Broliden P. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers. Proc. Natl. Acad. Sci. USA. 86:1989;8055-8058.
7. Goedert J., Mendez H., Drummond J. Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120. Lancet. 2:1989;1351-1354.
8. Emini E., Schleif W.A., Nunberg J.H., Conley A.J., Eda Y., Tokiyoshi S., Putney S.D., Matsushita S., Cobb K.E., Jett C.M., Eichberg J.W., Murthy K.K. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature. 355:1992;728-730.
9. Putkonen P., Thorstensson R., Ghavamazadeh L., Albert J., Hild K., Biberfeld G., Norrby E. Prevention of HIV-1 SIVSM infection by passive immunization in cynomologous monkeys. Nature. 352:1992;436-438.
10. Graham B., Wright P.F. Candidate Vaccine. NEJM. 33:1995;1331-1339.
11. Rinaldo C., Huang X., Fan Z. High levels of anti-HIV-1 memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1 infected long-term nonprogressors. J. Virol. 69:1995;5838-5842.
12. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 66:1989;1663-1666.
13. Borrow P., Lewicki H., Hahn B.H., Shaw G., Oldstone M.B.A. Virus-specific CD8 cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodefeciency virus type 1 infection. J. Virol. 68:1994;6103-6110.
14. Rowland-Jones S., et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:1995;59-64.
15. Rowland-Jones S., Nixon D., Aldhous M. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet. 341:1993;860-861.
16. Rosenberg E.S., Billings J.M., Caliendo A.M., et al. Vigorous HIV-1 specific CD4 T-cell responses associated with control of viremia. Science. 278:1997;1447-1450.
17. Wang B., Ugen K.E., Srikantan V., Agadjanyan M.G., Dang K., Sato A.I., Refaeli Y., Boyer J., William W.V., Weiner D.B. Genetic immunization generates neutralizing immune response against HIV-1. PNAS. 90:1993;4156-4160.
18. Wang B., Boyer J., Srikantan V., Ugen K., Gilbert L., Phan C., Dang K., Merva M., Coney L., Carrano R., Newman M., Agadjanyan M.G., Williams W.V., Weiner D.B. Induction of humoral and cellular immune responses to the human immunodeficiency type 1 virus in nonhuman primates by in vivo DNA inoculation. Virology. 211:1995;102.
19. Boyer J.D., Ugen K.E., Wang B., Chattergoon M., Tsai A., Merva M., Weiner D.B. Induction of a Thl type cellular immune responses to human immunodeficiency type 1 virus by in vivo DNA inoculation. Developments in biological standardization, modulation of the immune response to vaccine antigens. 92:1998;169-174.
20. Boyer J., Ugen K.E., Wang B., Agadjanyan M., Gilbert L., Bagarazzi M., Chattergoon M., Frost P., Javadian A., Williams V.N., Ciccarelli R.B., McCallus D., Coney L., Weiner D.B. Induction of protective humoral and cellular immune responses to HIV-1 in chimpanzees by in vivo DNA inoculation. Nat. Med. 3:1997;526-532.
21. MacGregor R.R., Boyer J.D., Ugen K.E., Lacy K.E., Bagarazzi M.L., Chattergoon M., Baine Y., Higgins T., Ciccarelli R., Coney L., Ginsberg R., Weiner D.B. First human trial of a DNA-based vaccine for the treatment of HIV-1 infection: safety and host responses. J. Inf. Dis. 178:1998;92-100.
22. Calarota S., Bratt G., Nordlund S., Hinkula J., Leandersson A., Sandstom E., Wahren B. Cellular cytotoxic response induced by DNA vaccination in HIV-1 infected patients. Lancet. 351:1998;1320-1325.
23. Boyer JD, Chattergoon, Ugen, Shah, Bennett, Cohen, Nyland, Lacy, Bagarazzi, Higgins, Baine, Ciccarelli, Ginsberg, MacCregor, Weiner. Enhancement of cellular immune response in HIV-1 seropositive individuals. Clin Immunol 1999;90:100-7.
24. Kim J., Ayyavoo V., Bagarazzi M.L., Dang K., Chattergoon M., Wang B., Boyer J., Weiner D.B. In vivo engineering of a cellular immune response by co-administration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:1997;816-826.
25. Kim J.J., Bagarazzi M.L., Trevedi N., Hu Y., Kazahaya K., Wilson D.M., Ciccarelli R., Dang K., Chattergoon M., Mahalingam S., Chalian A.A., Agadjanyan M.G., Boyer J., Wang B., Weiner D.B. Engineering of in vivo immune responses to DNA immunization via co-delivery of costimulatory molecule genes. Nat. Biotechnol. 14:1997;641-646.
26. Bagarazzi M.L., Boyer J.D., Ayyavoo V., Weiner D.B. Nucleic acid-based vaccines as an approach to immunization against human immunodeficiency virus type-1, current topics in microbiology and immunology. 1998;107-144 Springer Press, Berlin.
27. Cohen A., Boyer J.D., Weiner D.B. Modulating the immune response to genetic immunization. (DNA Vaccination) FASEB J. 12:1998;1611-1626.
28. + T-cell. Science. 270:1995;1811-1815.
29. Mackewicz C.E., Ortega H.W., Levy J.A. CD8 activity correleates with the clinical state of the infected individual. J. Clin. Invest. 87:1991;1462-1466.
30. + cell counts and HV-1 production by cells. Science. 270:1996;1811-1815.
31. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat. Med. 3:1997;533-540.
32. Kim J.J., Nottingham L., Sin J.I., Tsai A., Morrison L., Oh J.K., Wilson D.M., Ciccarelli R., Dang K., Chattergoon M., Chalian A.A., Agadjanyan M.G., Boyer J., Wang B., Weiner D.B. CD8 positive T-cells influence antigen-specific immune responses through the expression of chemokines. J. Clin. Invest. 102:1998;1112.
33. Wang R., Doolan D.L., Le T P., Hedstrom R.C., Coohan K.M., Charoenvit Y., Jones T.R., Hobart P., Margalith M., Ng J., Weiss W.R., Sedegah M., Taisne C., Norman J.A., Hoffman S.L. Induction of Antigen-Specific Cytotoxic T-Lymphocytes in Humans by a Malaria DNA Vaccine. Science. 282:1998;476-479.
34. Boyer J.D., Ugen K.E., Chattergoon M., Wang B., Agadjanyan M., Bagarazzi M.L., Shah A., Javadian A., Carrano R., Coney L., Williams W.V., Weiner D.B. DNA vaccination as anti-HIV immunotherapy in infected chimpanzees. J. Infect. Dis. 176:1997;1501-1509.